NCT02664103 - Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 23, 2016

Primary Completion Date

November 6, 2017

Study Completion Date

November 6, 2017

Conditions

Breast Cancer Metastatic

Interventions

DRUG

Fixed-dose combination of capecitabine and cyclophosphamide SAR439281

Pharmaceutical form:Tablet Route of administration: Oral

Trial Locations (5)

Investigational Site Number 356007, New Delhi

Investigational Site Number 356002, Mumbai

Investigational Site Number 356001, Vellore

Investigational Site Number 356008, Trivandrum

Investigational Site Number 356009, Kollkata